scholarly journals A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer’s disease

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Yong Kyoung Yoo ◽  
Jinsik Kim ◽  
Gangeun Kim ◽  
Young Soo Kim ◽  
Hye Yun Kim ◽  
...  
2010 ◽  
Vol 223 (2) ◽  
pp. 366-370 ◽  
Author(s):  
P. Lewczuk ◽  
J. Kornhuber ◽  
E. Vanmechelen ◽  
O. Peters ◽  
I. Heuser ◽  
...  

2009 ◽  
Vol 5 (4S_Part_9) ◽  
pp. P273-P273
Author(s):  
Susanne A. Funke ◽  
Lei Wang ◽  
Eva Birkmann ◽  
Franziska Henke ◽  
Oliver Bannach ◽  
...  

Lab on a Chip ◽  
2021 ◽  
Author(s):  
Hye Jin Kim ◽  
Dongsung Park ◽  
Gyihyaon Yun ◽  
Hongrae Kim ◽  
Hyug-Gi Kim ◽  
...  

Screening of cerebral amyloid angiopathy and Alzheimer's disease by analyzing plasma amyloid-β using a highly sensitive dielectrophoretic force-driven biosensor platform.


2010 ◽  
Vol 6 ◽  
pp. S159-S159
Author(s):  
Susanne A. Funke ◽  
Lei Wang ◽  
Pia Zißmann ◽  
Eva Birkmann ◽  
Phillip Görtz ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
pp. 1-16
Author(s):  
Qinyu Peng ◽  
Zhentao Zhang

Alzheimer’s disease (AD) is the most common neurodegenerative disorder. However, it still has no available disease‐modifying therapies. Its pathology cascade begins decades before symptomatic presentation. For these reasons, highly sensitive and highly specific fluid biomarkers should be developed for the early diagnosis of AD. In this study, the well‐established and emerging fluid biomarkers of AD are summarized, and recent advances on their role in early diagnosis and progression monitoring as well as their correlations with AD pathology are highlighted. Future prospects and related research directions are also discussed.


2015 ◽  
Vol 58 (17) ◽  
pp. 6972-6983 ◽  
Author(s):  
Hualong Fu ◽  
Mengchao Cui ◽  
Liu Zhao ◽  
Peiyu Tu ◽  
Kaixiang Zhou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document